These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 309271

  • 1. The effects of aromatic amino acid decarboxylase inhibitors on plasma concentrations of 5-hydroxytryptophan in man.
    Magnussen I, Engbaek F.
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):36-42. PubMed ID: 309271
    [Abstract] [Full Text] [Related]

  • 2. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I, Jensen TS, Rand JH, Van Woert MH.
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [Abstract] [Full Text] [Related]

  • 3. Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
    Magnussen I, Van Woert MH.
    Eur J Clin Pharmacol; 1982 Sep; 23(1):81-6. PubMed ID: 6182005
    [Abstract] [Full Text] [Related]

  • 4. The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
    Young SN, Gauthier S, Chouinard G, Anderson GM, Purdy WC.
    J Neural Transm; 1982 Sep; 53(1):83-7. PubMed ID: 6801200
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of l-5-hydroxytryptophan in healthy subjects.
    Westenberg HG, Gerritsen TW, Meijer BA, van Praag HM.
    Psychiatry Res; 1982 Dec; 7(3):373-85. PubMed ID: 6187038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of intravenously administered L-5-hydroxytryptophan in man.
    Magnussen I, Nielsen-Kudsk F.
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):308-14. PubMed ID: 311987
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in steady state.
    Magnussen I, Nielsen-Kudsk F.
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):257-62. PubMed ID: 6966118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of some serotoninergic agents on the rectal temperature of the domestic fowl (Gallus domesticus).
    Osuide G, Wambebe C, Bodhankar S.
    Neuropharmacology; 1984 Dec; 23(12A):1407-14. PubMed ID: 6241299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine.
    Huebert ND, Palfreyman MG, Haegele KD.
    Drug Metab Dispos; 1983 Dec; 11(3):195-200. PubMed ID: 6135575
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W, Pagliusi SR, Müller F.
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.